Predictors of Relapse in Ozanimod-Treated Patients with Multiple Sclerosis: Ad Hoc Analysis from the Open-Label Extension DAYBREAK Study

Authors
Category Systematic review
ConferenceMSmilan2023
Year 2023
This article has no abstract
Epistemonikos ID: 2e9bea8bd2038705e84bb5831cbd805be8208b10
First added on: Jan 10, 2026